Recruiting trial = ; Ongoing trial = ; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

SPAIN

Madrid
MADRID

A Multicentre, Multinational, Open-Label, Randomised, Parallel Group Clinical Trial of Tobrineb®/Actitob®/Bramitob® (Tobramycin Solution for Nebulisation, 300mg Twice Daily in 4mL Unit Dose Vials) Compared to TOBI® in the Treatment of Patients With Cystic Fibrosis and Chronic Infection With Pseudomonas Aeruginosa (Phase III) - ES (completed)

Hospital Universitario La Paz

Servicio de Neumología

More details

SPAIN

Madrid
MADRID

An Open-label, Crossover, Interventional Phase IV Study to Compare the Ease of Use of TIP With TIS and Nebulized Colistimethate for the Treatment of Pulmonary Pseudomonas Aeruginosa in Patients With Cystic Fibrosis - ES (Completed)

Hospital Universitario La Paz

Servicio de Neumología

More details